131 related articles for article (PubMed ID: 30716337)
1. KLF4 sensitizes the colon cancer cell HCT-15 to cisplatin by altering the expression of HMGB1 and hTERT.
Yadav SS; Kumar M; Varshney A; Yadava PK
Life Sci; 2019 Mar; 220():169-176. PubMed ID: 30716337
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of glutathione synthesis reverses Krüppel-like factor 4-mediated cisplatin resistance.
Jia Y; Zhang W; Liu H; Peng L; Yang Z; Lou J
Cancer Chemother Pharmacol; 2012 Feb; 69(2):377-85. PubMed ID: 21833590
[TBL] [Abstract][Full Text] [Related]
3. Krüppel-Like Factor 4 Enhances Sensitivity of Cisplatin to Esophageal Squamous Cell Carcinoma (ESCC) Cells.
Chen C; Ma Z; Zhang H; Liu X; Yu Z
Med Sci Monit; 2017 Jul; 23():3353-3359. PubMed ID: 28694421
[TBL] [Abstract][Full Text] [Related]
4. KLF4 downregulates hTERT expression and telomerase activity to inhibit lung carcinoma growth.
Hu W; Jia Y; Xiao X; Lv K; Chen Y; Wang L; Luo X; Liu T; Li W; Li Y; Zhang C; Yu Z; Huang W; Sun B; Deng WG
Oncotarget; 2016 Aug; 7(33):52870-52887. PubMed ID: 27153563
[TBL] [Abstract][Full Text] [Related]
5. KLF4 signalling in carcinogenesis and epigenetic regulation of hTERT.
Yadav SS; Nair RR; Yadava PK
Med Hypotheses; 2018 Jun; 115():50-53. PubMed ID: 29685197
[TBL] [Abstract][Full Text] [Related]
6. Interference with HMGB1 increases the sensitivity to chemotherapy drugs by inhibiting HMGB1-mediated cell autophagy and inducing cell apoptosis.
Zhang R; Li Y; Wang Z; Chen L; Dong X; Nie X
Tumour Biol; 2015 Nov; 36(11):8585-92. PubMed ID: 26040768
[TBL] [Abstract][Full Text] [Related]
7. Krüppel-like transcription factor 4 contributes to maintenance of telomerase activity in stem cells.
Wong CW; Hou PS; Tseng SF; Chien CL; Wu KJ; Chen HF; Ho HN; Kyo S; Teng SC
Stem Cells; 2010 Sep; 28(9):1510-7. PubMed ID: 20629177
[TBL] [Abstract][Full Text] [Related]
8. Krüppel-like factor 4 promotes high-mobility group box 1-induced chemotherapy resistance in osteosarcoma cells.
Huang J; Liu K; Song D; Ding M; Wang J; Jin Q; Ni J
Cancer Sci; 2016 Mar; 107(3):242-9. PubMed ID: 26676883
[TBL] [Abstract][Full Text] [Related]
9. Synergy of theophylline reduces necrotic effect of berberine, induces cell cycle arrest and PARP, HMGB1, Bcl-2 family mediated apoptosis in MDA-MB-231 breast cancer cells.
Hashemi-Niasari F; Rabbani-Chadegani A; Razmi M; Fallah S
Biomed Pharmacother; 2018 Oct; 106():858-867. PubMed ID: 30119256
[TBL] [Abstract][Full Text] [Related]
10. Mucuna pruriens (L.) DC chemo sensitize human breast cancer cells via downregulation of prolactin-mediated JAK2/STAT5A signaling.
Sinha S; Sharma S; Vora J; Shah H; Srivastava A; Shrivastava N
J Ethnopharmacol; 2018 May; 217():23-35. PubMed ID: 29427634
[TBL] [Abstract][Full Text] [Related]
11. KLF4, a miR-32-5p targeted gene, promotes cisplatin-induced apoptosis by upregulating BIK expression in prostate cancer.
Zhang L; Li X; Chao Y; He R; Liu J; Yuan Y; Zhao W; Han C; Song X
Cell Commun Signal; 2018 Sep; 16(1):53. PubMed ID: 30176890
[TBL] [Abstract][Full Text] [Related]
12. Inhibiting the cytoplasmic location of HMGB1 reverses cisplatin resistance in human cervical cancer cells.
Xia J; Yu X; Song X; Li G; Mao X; Zhang Y
Mol Med Rep; 2017 Jan; 15(1):488-494. PubMed ID: 27959427
[TBL] [Abstract][Full Text] [Related]
13. RNF138 confers cisplatin resistance in gastric cancer cells via activating Chk1 signaling pathway.
Lu Y; Han D; Liu W; Huang R; Ou J; Chen X; Zhang X; Wang X; Li S; Wang L; Liu C; Miao S; Wang L; Ma C; Song W
Cancer Biol Ther; 2018; 19(12):1128-1138. PubMed ID: 30260263
[TBL] [Abstract][Full Text] [Related]
14. RNA silencing of integrin-linked kinase increases the sensitivity of the A549 lung cancer cell line to cisplatin and promotes its apoptosis.
Zhao X; Xu Z; Wang Z; Wu Z; Gong Y; Zhou L; Xiang Y
Mol Med Rep; 2015 Jul; 12(1):960-6. PubMed ID: 25760437
[TBL] [Abstract][Full Text] [Related]
15. KLF4 promotes the expression, translocation, and releas eof HMGB1 in RAW264.7 macrophages in response to LPS.
Liu J; Liu Y; Zhang H; Chen G; Wang K; Xiao X
Shock; 2008 Sep; 30(3):260-6. PubMed ID: 18197146
[TBL] [Abstract][Full Text] [Related]
16. Silencing GOLPH3 gene expression reverses resistance to cisplatin in HT29 colon cancer cells via multiple signaling pathways.
Zhou ZP; Wang LP; Hong ZS; Qiu CZ; Wang MZ; Chen ZX; Tang LF; Yu WS; Wang CX
Int J Oncol; 2018 Sep; 53(3):1183-1192. PubMed ID: 30015866
[TBL] [Abstract][Full Text] [Related]
17. Krüppel-Like Factor 4 Enhances Sensitivity of Cisplatin to Lung Cancer Cells and Inhibits Regulating Epithelial-to-Mesenchymal Transition.
Liu S; Yang H; Chen Y; He B; Chen Q
Oncol Res; 2016; 24(2):81-7. PubMed ID: 27296948
[TBL] [Abstract][Full Text] [Related]
18. Role of Krüppel-Like Factor 4 in the Maintenance of Chemoresistance of Anaplastic Thyroid Cancer.
Lee SI; Kim DK; Seo EJ; Choi EJ; Kwon YW; Jang IH; Lee JC; Kim HY; Shong M; Kim JH; Kim SJ
Thyroid; 2017 Nov; 27(11):1424-1432. PubMed ID: 28920531
[TBL] [Abstract][Full Text] [Related]
19. Pretreatment with the γ-secretase inhibitor DAPT sensitizes drug-resistant ovarian cancer cells to cisplatin by downregulation of Notch signaling.
Wang M; Ma X; Wang J; Wang L; Wang Y
Int J Oncol; 2014 Apr; 44(4):1401-9. PubMed ID: 24535252
[TBL] [Abstract][Full Text] [Related]
20. 15-deoxy-Delta12,14 prostaglandin J2 up-regulates Kruppel-like factor 4 expression independently of peroxisome proliferator-activated receptor gamma by activating the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signal transduction pathway in HT-29 colon cancer cells.
Chen ZY; Tseng CC
Mol Pharmacol; 2005 Nov; 68(5):1203-13. PubMed ID: 16077033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
